 |
8 Diseases |  |
0 Trials |
|
0 Trials |  |
20 News |  |
- | lotamilast (E 6005) / Eisai
Clinical, PK/PD data, Journal: Pharmacokinetic disposition of topical phosphodiesterase-4 inhibitor E6005 in patients with atopic dermatitis. (Pubmed Central) - Aug 8, 2019
Exposure to topical E6005 is associated with the eczema-associated area, however, that is not distinctly associated with its adverse drug reactions occurred after drug applications possibly due to E6005's characteristics of tissue distribution.
- | lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
Trial completion: Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (clinicaltrials.gov) - Jul 19, 2018
P2, N=110, Completed, Sponsor: Dermavant Sciences GmbH
Exposure to topical E6005 is associated with the eczema-associated area, however, that is not distinctly associated with its adverse drug reactions occurred after drug applications possibly due to E6005's characteristics of tissue distribution. Active, not recruiting --> Completed
- | lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
Trial initiation date: Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (clinicaltrials.gov) - Mar 3, 2018
P1, N=24, Recruiting, Sponsor: Dermavant Sciences GmbH
Active, not recruiting --> Completed Initiation date: Jan 2018 --> Feb 2018
- | lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
Enrollment open, Trial initiation date: Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (clinicaltrials.gov) - Feb 22, 2018
P2, N=100, Recruiting, Sponsor: Dermavant Sciences GmbH
Initiation date: Jan 2018 --> Feb 2018 Not yet recruiting --> Recruiting | Initiation date: Jan 2018 --> Jan 2018
- | lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
New P1 trial: Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (clinicaltrials.gov) - Jan 30, 2018
P1, N=24, Recruiting, Sponsor: Dermavant Sciences GmbH
- | lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
New P2 trial: Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis (clinicaltrials.gov) - Jan 9, 2018
P2, N=100, Not yet recruiting, Sponsor: Dermavant Sciences GmbH
- |||| lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
Trial completion: Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis (clinicaltrials.gov) - Jul 26, 2017
P2, N=157, Completed, Sponsor: Dermavant Sciences, Inc.
Not yet recruiting --> Recruiting | Initiation date: Jan 2018 --> Jan 2018 Active, not recruiting --> Completed
- ||| lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
Enrollment closed: Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis (clinicaltrials.gov) - Jun 8, 2017
P2, N=150, Active, not recruiting, Sponsor: Dermavant Sciences, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||| lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
Enrollment open: Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis (clinicaltrials.gov) - Feb 9, 2017
P2, N=150, Recruiting, Sponsor: Dermavant Sciences, Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
New P2 trial: Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis (clinicaltrials.gov) - Nov 1, 2016
P2, N=150, Not yet recruiting, Sponsor: Dermavant Sciences, Inc.
- |||| lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
Trial completion: A Phase 2 Study of E6005 in Patients With Atopic Dermatitis (clinicaltrials.gov) - Jan 20, 2014
P2, N=78, Completed, Sponsor: Eisai Co., Ltd.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| lotamilast 0.5% ointment (DMVT-501 0.5% ointment) / Roivant
New P2 trial: A Phase 2 Study of E6005 in Patients With Atopic Dermatitis (clinicaltrials.gov) - Oct 26, 2011
P2, N=78, Completed, Sponsor: Eisai Co., Ltd.